Package Leaflet: Information for the User
Accusol 35 Potassium 4 mmol/l, solution for hemofiltration, hemodialysis, and hemodiafiltration
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Contents of the pack
5 Conservation of Accusol 35 Potassium 4 mmol/l
Accusol 35 Potassium 4 mmol/l is a solution for hemofiltration, hemodialysis, and hemodiafiltration.
Accusol 35 Potassium 4 mmol/l is indicated in patients with acute or chronic renal failure.
It cleans the blood of waste products; corrects acidosis or alkalinity and abnormal levels of salts in the blood. As a replacement solution in hemodiafiltration and hemofiltration, it can also be used as a source of salts and water for hydration.
The Accusol 35 solutions are presented in a two-compartment bag (bicompartimental) that does not contain PVC. A long seal (seal between the chambers) separates the two chambers. Before use, the solutions from the two Accusol 35 chambers must first be mixed by opening the long seal (seal between the chambers), followed by the opening of the short SafetyMoon seal located near the access port.
Accusol 35 Potassium 4 mmol/l will be given to you especially if you have normal or low potassium levels.
The Accusol 35 solutions should only be used under the supervision of a doctor.
Your doctor will make sure that you have adequate blood access to perform the procedure and that there is no risk of bleeding.
The Accusol 35 solutions are available in different concentrations of potassium and glucose. The levels of potassium and glucose in your blood will be carefully checked to ensure that the most suitable Accusol 35 formulation is used.
Your doctor will not give you Accusol 35 Potassium 4 mmol/l
if you do not have good access to your veins and/or arteries
if you have a high risk of bleeding
if you have high levels of bicarbonate in your blood
if you have high levels of potassium in your blood
if you have a clinical condition in which the levels of acidity or alkalinity in your blood may worsen
if you have a renal disorder in which waste products cannot be removed from the blood by hemofiltration.
Warnings and precautions
Accusol 35 Potassium 4 mmol/l should only be used by or under the supervision of a doctor with experience in hemofiltration, hemodialysis, or hemodiafiltration techniques.
Your doctor
will measure the acidity, salt levels, and waste products in your blood
will ensure that the levels are correct and will closely monitor them during treatment
will ensure that a good fluid balance is maintained
will closely monitor your blood glucose levels, especially if you are diabetic
will regularly measure the potassium levels in your blood
will ensure, before use, that the contents of both chambers are mixed by opening the long seal (seal between the chambers), followed by the opening of the short SafetyMoon seal located near the access port. If the doctor performs perfusion with an unmixed solution, your bicarbonate level in the blood may increase. This can cause side effects such as nausea, drowsiness, headache, changes in heart rhythm, and difficulty breathing.
Other medicines and Accusol 35 Potassium 4 mmol/l
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
The administration of Accusol 35 Potassium 4 mmol/l may affect the action of other medicines.
if you are diabetic, your blood glucose level should be rigorously checked. Your insulin dose will be adjusted as necessary since this solution contains glucose.
if you are taking vitamin D or other medicines that contain calcium, your calcium level in the blood may be altered.
if you are taking additional sodium bicarbonate, there is a greater risk of abnormal salt and alkali levels (alkalosis) in your blood.
if you are taking heart medicines called cardiac glycosides, you may need potassium supplements. Your doctor will closely monitor you during treatment.
Pregnancy and breastfeeding
Tell your doctor if you are pregnant or breastfeeding. The doctor will evaluate the benefits of Accusol 35 Potassium 4 mmol/l against the risks.
Depending on your treatment, your doctor will give you Accusol 35 Potassium 4 mmol/l through the tube of the dialysis machine.
The hemofiltration, hemodialysis, or hemodiafiltration treatment you receive will depend on your clinical condition, physical examination, laboratory test results, and response to treatment.
Your doctor will determine the suitable formula and amount of Accusol 35 solutions for your clinical condition.
Dose and frequency
Your doctor will decide and adjust the volume and rate of administration of the solution to be given.
The amount of fluid needed will depend on the use of Accusol 35 Potassium 4 mmol/l.
If you are an adult or elderly patient and
are being treated with Accusol 35 Potassium 4 mmol/l as a replacement solution due to chronic renal failure, you will be given 7 to 35 ml/kg/h or more
are being treated with Accusol 35 Potassium 4 mmol/l as a replacement solution due to acute renal failure, you will be given 20 to 35 ml/kg/h or more
are being treated with Accusol 35 Potassium 4 mmol/l as a dialysis solution due to chronic or acute renal failure, the amount of solution will be determined according to the frequency and duration of treatment.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The rare possible side effects of Accusol 35 Potassium 4 mmol/l (which occur in less than 1 in 1000 patients)include:
Low blood glucose level (hypoglycemia).
You may experience other side effects. It is possible that these side effects are not all due to the solutions or treatment. The possible side effects that may occur are:
Decrease (hypovolemia) or increase (hypervolemia) in body fluid volume
Decrease (hypotension) or increase (hypertension) in blood pressure
Very low phosphate levels in the blood (hypophosphatemia)
Changes in blood alkali levels (alkalosis)
Dizziness
Vomiting
Muscle cramps
Bleeding disorders
Infection
Difficulty breathing, irregular breathing (caused by air bubbles in the bloodstream)
Changes in the levels of different salts in the blood (e.g. changes in sodium, potassium, calcium in the blood)
Increased blood coagulation
Reporting of side effects
If you experience side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines:
www.notificaRAM.es
Keep this medicine out of the sight and reach of children.
Do not refrigerate or freeze.
Do not use this medicine after the expiry date which is stated on the label and on the carton after EXP. The expiry date is the last day of the month stated.
Your doctor will not use Accusol 35 if the solution is not transparent or the packaging is damaged.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Medicine name
Accusol 35, solution for hemofiltration, hemodialysis, and hemodiafiltration.
Composition of the Accusol 35 solution:
Composition | Per 1000 ml Accusol 35 |
Calcium chloride dihydrate | 0.343 g |
Magnesium chloride hexahydrate | 0.136 g |
Sodium chloride | 7.52 g |
Sodium bicarbonate | 13.4 g |
The 5000 ml of final solution result from the mixture of 3750 ml of solution ‘A’ with 1250 ml of solution ‘B’.
Ionic composition of the final solution:
Per 1000 ml Accusol 35 | |
Calcium (Ca++) | 1.75 mmol |
Magnesium (Mg++) | 0.5 mmol |
Sodium (Na+) | 140 mmol |
Chloride (Cl-) | 109.3 mmol |
Bicarbonate (HCO3-) | 35 mmol |
Theoretical osmolality | 287 mOsm/l |
The other components are: water for injections, hydrochloric acid, sodium hydroxide, and disodium phosphate dihydrate.
Appearance of Accusol 35 and pack contents
Accusol 35 is supplied in a cardboard box containing two 5-liter two-chamber bags that do not contain PVC.
Each bag is wrapped in an overbag.
The solution in the bag is transparent and colorless.
Marketing authorization holder:
Nikkiso Belgium
Industriepark 6
3300 Tienen
Belgium
Local representative:
Palex Medical S.A.
Jesus Serra Santamans, 5
08174 Sant Cugat del Valles
Spain
Manufacturer:
Baxter Healthcare S.A.
Moneen Road
Castlebar
County Mayo – Ireland
or
Serumwerk Bernburg AG
Hallesche Landstrasse 105b
06406 Bernburg
Germany
Date of last revision of this leaflet: 07/2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Accusol is a registered trademark of Nikkiso International Inc.
The average price of ACCUSOL 35 POTASSIUM 4 mmol/L SOLUTION FOR HEMOFILTRATION, HEMODIALYSIS AND HEMODIAFILTRATION in October, 2025 is around 39.95 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.